N-[4-[(dimethylamino)methyl]phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;N-[4-(imidazol-1-ylmethyl)phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[(5-methyl-2-phenyltriazol-4-yl)methyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[3-(1-methylpyrazol-3-yl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-(2-morpholin-4-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;1-[3-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]phenyl]imidazolidin-2-one;3-methyl-N-(4-pyrimidin-2-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine

C135H135F3N46O3 — CID 158017945

IUPACN-[4-[(dimethylamino)methyl]phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;N-[4-(imidazol-1-ylmethyl)phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[(5-methyl-2-phenyltriazol-4-yl)methyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[3-(1-methylpyrazol-3-yl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-(2-morpholin-4-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;1-[3-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]phenyl]imidazolidin-2-one;3-methyl-N-(4-pyrimidin-2-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine
SMILESCc1[nH]nc2ccnc(Nc3cc(C(F)(F)F)ccc3N3CCOCC3)c12.Cc1[nH]nc2ccnc(Nc3ccc(-c4ncccn4)cc3)c12.Cc1[nH]nc2ccnc(Nc3ccc(CN(C)C)cc3)c12.Cc1[nH]nc2ccnc(Nc3ccc(Cn4ccnc4)cc3)c12.Cc1[nH]nc2ccnc(Nc3cccc(-c4ccn(C)n4)c3)c12.Cc1[nH]nc2ccnc(Nc3cccc(N4CCNC4=O)c3)c12.Cc1[nH]nc2ccnc(Nc3ccccc3N3CCOCC3)c12.Cc1nn(-c2ccccc2)nc1CNc1nccc2n[nH]c(C)c12
InChIInChI=1S/C18H18F3N5O.C17H17N7.C17H14N6.2C17H16N6.C17H19N5O.C16H16N6O.C16H19N5/c1-11-16-13(25-24-11)4-5-22-17(16)23-14-10-12(18(19,20)21)2-3-15(14)26-6-8-27-9-7-26;1-11-15(23-24(22-11)13-6-4-3-5-7-13)10-19-17-16-12(2)20-21-14(16)8-9-18-17;1-11-15-14(23-22-11)7-10-20-17(15)21-13-5-3-12(4-6-13)16-18-8-2-9-19-16;1-11-16-15(21-20-11)6-8-18-17(16)19-13-5-3-4-12(10-13)14-7-9-23(2)22-14;1-12-16-15(22-21-12)6-7-19-17(16)20-14-4-2-13(3-5-14)10-23-9-8-18-11-23;1-12-16-14(21-20-12)6-7-18-17(16)19-13-4-2-3-5-15(13)22-8-10-23-11-9-22;1-10-14-13(21-20-10)5-6-17-15(14)19-11-3-2-4-12(9-11)22-8-7-18-16(22)23;1-11-15-14(20-19-11)8-9-17-16(15)18-13-6-4-12(5-7-13)10-21(2)3/h2-5,10H,6-9H2,1H3,(H,22,23)(H,24,25);3-9H,10H2,1-2H3,(H,18,19)(H,20,21);2-10H,1H3,(H,20,21)(H,22,23);3-10H,1-2H3,(H,18,19)(H,20,21);2-9,11H,10H2,1H3,(H,19,20)(H,21,22);2-7H,8-11H2,1H3,(H,18,19)(H,20,21);2-6,9H,7-8H2,1H3,(H,17,19)(H,18,23)(H,20,21);4-9H,10H2,1-3H3,(H,17,18)(H,19,20)
InChIKeyFFRXNRDYEYBYRC-UHFFFAOYSA-N
MW2506.88 g/mol
LogP25.22
Rot. Bonds27

About N-[4-[(dimethylamino)methyl]phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;N-[4-(imidazol-1-ylmethyl)phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[(5-methyl-2-phenyltriazol-4-yl)methyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[3-(1-methylpyrazol-3-yl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-(2-morpholin-4-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;1-[3-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]phenyl]imidazolidin-2-one;3-methyl-N-(4-pyrimidin-2-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine

N-[4-[(dimethylamino)methyl]phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;N-[4-(imidazol-1-ylmethyl)phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[(5-methyl-2-phenyltriazol-4-yl)methyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[3-(1-methylpyrazol-3-yl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-(2-morpholin-4-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;1-[3-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]phenyl]imidazolidin-2-one;3-methyl-N-(4-pyrimidin-2-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine (PubChem CID 158017945) has the molecular formula C135H135F3N46O3 and a molecular weight of 2506.88 g/mol. Its IUPAC name is N-[4-[(dimethylamino)methyl]phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;N-[4-(imidazol-1-ylmethyl)phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[(5-methyl-2-phenyltriazol-4-yl)methyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[3-(1-methylpyrazol-3-yl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-(2-morpholin-4-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;1-[3-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]phenyl]imidazolidin-2-one;3-methyl-N-(4-pyrimidin-2-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine.

Molecular Properties

Compound NameN-[4-[(dimethylamino)methyl]phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;N-[4-(imidazol-1-ylmethyl)phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[(5-methyl-2-phenyltriazol-4-yl)methyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[3-(1-methylpyrazol-3-yl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-(2-morpholin-4-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;1-[3-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]phenyl]imidazolidin-2-one;3-methyl-N-(4-pyrimidin-2-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine
PubChem CID158017945
Molecular FormulaC135H135F3N46O3
Molecular Weight2506.88 g/mol
Exact Mass2505.18
IUPAC NameN-[4-[(dimethylamino)methyl]phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;N-[4-(imidazol-1-ylmethyl)phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[(5-methyl-2-phenyltriazol-4-yl)methyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[3-(1-methylpyrazol-3-yl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-(2-morpholin-4-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;1-[3-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]phenyl]imidazolidin-2-one;3-methyl-N-(4-pyrimidin-2-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine
SMILESCc1[nH]nc2ccnc(Nc3cc(C(F)(F)F)ccc3N3CCOCC3)c12.Cc1[nH]nc2ccnc(Nc3ccc(-c4ncccn4)cc3)c12.Cc1[nH]nc2ccnc(Nc3ccc(CN(C)C)cc3)c12.Cc1[nH]nc2ccnc(Nc3ccc(Cn4ccnc4)cc3)c12.Cc1[nH]nc2ccnc(Nc3cccc(-c4ccn(C)n4)c3)c12.Cc1[nH]nc2ccnc(Nc3cccc(N4CCNC4=O)c3)c12.Cc1[nH]nc2ccnc(Nc3ccccc3N3CCOCC3)c12.Cc1nn(-c2ccccc2)nc1CNc1nccc2n[nH]c(C)c12
InChIInChI=1S/C18H18F3N5O.C17H17N7.C17H14N6.2C17H16N6.C17H19N5O.C16H16N6O.C16H19N5/c1-11-16-13(25-24-11)4-5-22-17(16)23-14-10-12(18(19,20)21)2-3-15(14)26-6-8-27-9-7-26;1-11-15(23-24(22-11)13-6-4-3-5-7-13)10-19-17-16-12(2)20-21-14(16)8-9-18-17;1-11-15-14(23-22-11)7-10-20-17(15)21-13-5-3-12(4-6-13)16-18-8-2-9-19-16;1-11-16-15(21-20-11)6-8-18-17(16)19-13-5-3-4-12(10-13)14-7-9-23(2)22-14;1-12-16-15(22-21-12)6-7-19-17(16)20-14-4-2-13(3-5-14)10-23-9-8-18-11-23;1-12-16-14(21-20-12)6-7-18-17(16)19-13-4-2-3-5-15(13)22-8-10-23-11-9-22;1-10-14-13(21-20-10)5-6-17-15(14)19-11-3-2-4-12(9-11)22-8-7-18-16(22)23;1-11-15-14(20-19-11)8-9-17-16(15)18-13-6-4-12(5-7-13)10-21(2)3/h2-5,10H,6-9H2,1H3,(H,22,23)(H,24,25);3-9H,10H2,1-2H3,(H,18,19)(H,20,21);2-10H,1H3,(H,20,21)(H,22,23);3-10H,1-2H3,(H,18,19)(H,20,21);2-9,11H,10H2,1H3,(H,19,20)(H,21,22);2-7H,8-11H2,1H3,(H,18,19)(H,20,21);2-6,9H,7-8H2,1H3,(H,17,19)(H,18,23)(H,20,21);4-9H,10H2,1-3H3,(H,17,18)(H,19,20)
InChIKeyFFRXNRDYEYBYRC-UHFFFAOYSA-N
XLogP25.22
TPSA581.45 Ų
H-Bond Donors17
H-Bond Acceptors39
Rotatable Bonds27
Heavy Atoms187
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002506.88
LogP ≤ 525.22
H-Bond Donors ≤ 517
H-Bond Acceptors ≤ 1039

Analyze N-[4-[(dimethylamino)methyl]phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;N-[4-(imidazol-1-ylmethyl)phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[(5-methyl-2-phenyltriazol-4-yl)methyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[3-(1-methylpyrazol-3-yl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-(2-morpholin-4-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;1-[3-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]phenyl]imidazolidin-2-one;3-methyl-N-(4-pyrimidin-2-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of N-[4-[(dimethylamino)methyl]phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;N-[4-(imidazol-1-ylmethyl)phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[(5-methyl-2-phenyltriazol-4-yl)methyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[3-(1-methylpyrazol-3-yl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-(2-morpholin-4-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;1-[3-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]phenyl]imidazolidin-2-one;3-methyl-N-(4-pyrimidin-2-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine?
The IUPAC name of N-[4-[(dimethylamino)methyl]phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;N-[4-(imidazol-1-ylmethyl)phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[(5-methyl-2-phenyltriazol-4-yl)methyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[3-(1-methylpyrazol-3-yl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-(2-morpholin-4-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;1-[3-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]phenyl]imidazolidin-2-one;3-methyl-N-(4-pyrimidin-2-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine (CID 158017945) is N-[4-[(dimethylamino)methyl]phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;N-[4-(imidazol-1-ylmethyl)phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[(5-methyl-2-phenyltriazol-4-yl)methyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[3-(1-methylpyrazol-3-yl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-(2-morpholin-4-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;1-[3-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]phenyl]imidazolidin-2-one;3-methyl-N-(4-pyrimidin-2-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine.
What is the SMILES notation for N-[4-[(dimethylamino)methyl]phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;N-[4-(imidazol-1-ylmethyl)phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[(5-methyl-2-phenyltriazol-4-yl)methyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[3-(1-methylpyrazol-3-yl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-(2-morpholin-4-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;1-[3-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]phenyl]imidazolidin-2-one;3-methyl-N-(4-pyrimidin-2-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine?
The canonical SMILES for N-[4-[(dimethylamino)methyl]phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;N-[4-(imidazol-1-ylmethyl)phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[(5-methyl-2-phenyltriazol-4-yl)methyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[3-(1-methylpyrazol-3-yl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-(2-morpholin-4-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;1-[3-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]phenyl]imidazolidin-2-one;3-methyl-N-(4-pyrimidin-2-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine is Cc1[nH]nc2ccnc(Nc3cc(C(F)(F)F)ccc3N3CCOCC3)c12.Cc1[nH]nc2ccnc(Nc3ccc(-c4ncccn4)cc3)c12.Cc1[nH]nc2ccnc(Nc3ccc(CN(C)C)cc3)c12.Cc1[nH]nc2ccnc(Nc3ccc(Cn4ccnc4)cc3)c12.Cc1[nH]nc2ccnc(Nc3cccc(-c4ccn(C)n4)c3)c12.Cc1[nH]nc2ccnc(Nc3cccc(N4CCNC4=O)c3)c12.Cc1[nH]nc2ccnc(Nc3ccccc3N3CCOCC3)c12.Cc1nn(-c2ccccc2)nc1CNc1nccc2n[nH]c(C)c12.
What is the InChIKey of N-[4-[(dimethylamino)methyl]phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;N-[4-(imidazol-1-ylmethyl)phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[(5-methyl-2-phenyltriazol-4-yl)methyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[3-(1-methylpyrazol-3-yl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-(2-morpholin-4-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;1-[3-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]phenyl]imidazolidin-2-one;3-methyl-N-(4-pyrimidin-2-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine?
The InChIKey is FFRXNRDYEYBYRC-UHFFFAOYSA-N. The full InChI is InChI=1S/C18H18F3N5O.C17H17N7.C17H14N6.2C17H16N6.C17H19N5O.C16H16N6O.C16H19N5/c1-11-16-13(25-24-11)4-5-22-17(16)23-14-10-12(18(19,20)21)2-3-15(14)26-6-8-27-9-7-26;1-11-15(23-24(22-11)13-6-4-3-5-7-13)10-19-17-16-12(2)20-21-14(16)8-9-18-17;1-11-15-14(23-22-11)7-10-20-17(15)21-13-5-3-12(4-6-13)16-18-8-2-9-19-16;1-11-16-15(21-20-11)6-8-18-17(16)19-13-5-3-4-12(10-13)14-7-9-23(2)22-14;1-12-16-15(22-21-12)6-7-19-17(16)20-14-4-2-13(3-5-14)10-23-9-8-18-11-23;1-12-16-14(21-20-12)6-7-18-17(16)19-13-4-2-3-5-15(13)22-8-10-23-11-9-22;1-10-14-13(21-20-10)5-6-17-15(14)19-11-3-2-4-12(9-11)22-8-7-18-16(22)23;1-11-15-14(20-19-11)8-9-17-16(15)18-13-6-4-12(5-7-13)10-21(2)3/h2-5,10H,6-9H2,1H3,(H,22,23)(H,24,25);3-9H,10H2,1-2H3,(H,18,19)(H,20,21);2-10H,1H3,(H,20,21)(H,22,23);3-10H,1-2H3,(H,18,19)(H,20,21);2-9,11H,10H2,1H3,(H,19,20)(H,21,22);2-7H,8-11H2,1H3,(H,18,19)(H,20,21);2-6,9H,7-8H2,1H3,(H,17,19)(H,18,23)(H,20,21);4-9H,10H2,1-3H3,(H,17,18)(H,19,20).
What are the key properties of N-[4-[(dimethylamino)methyl]phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;N-[4-(imidazol-1-ylmethyl)phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[(5-methyl-2-phenyltriazol-4-yl)methyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[3-(1-methylpyrazol-3-yl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-(2-morpholin-4-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;1-[3-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]phenyl]imidazolidin-2-one;3-methyl-N-(4-pyrimidin-2-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine?
N-[4-[(dimethylamino)methyl]phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;N-[4-(imidazol-1-ylmethyl)phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[(5-methyl-2-phenyltriazol-4-yl)methyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[3-(1-methylpyrazol-3-yl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-(2-morpholin-4-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;1-[3-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]phenyl]imidazolidin-2-one;3-methyl-N-(4-pyrimidin-2-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine has a molecular weight of 2506.88 g/mol, XLogP of 25.22, 27 rotatable bonds, 17 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for N-[4-[(dimethylamino)methyl]phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;N-[4-(imidazol-1-ylmethyl)phenyl]-3-methyl-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[(5-methyl-2-phenyltriazol-4-yl)methyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[3-(1-methylpyrazol-3-yl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-(2-morpholin-4-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine;3-methyl-N-[2-morpholin-4-yl-5-(trifluoromethyl)phenyl]-2H-pyrazolo[4,3-c]pyridin-4-amine;1-[3-[(3-methyl-2H-pyrazolo[4,3-c]pyridin-4-yl)amino]phenyl]imidazolidin-2-one;3-methyl-N-(4-pyrimidin-2-ylphenyl)-2H-pyrazolo[4,3-c]pyridin-4-amine is sourced from PubChem (CID 158017945), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).